Works matching IS 01615505 AND DT 2021 AND VI 62 AND IP 9

Results: 23

The Annual Journal Impact Factor Saga.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.121.262860

By:

Czernin, Johannes

Publication type:

Article

Leadership Focus on Advancing Cancer Research and Treatment: A Conversation Between Johannes Czernin, Caius Radu, and Antoni Ribas.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1178, doi. 10.2967/jnumed.121.262937

By:

Czernin, Johannes;
Radu, Caius;
Ribas, Antoni

Publication type:

Article

FDA Encourages Inclusion of Incurable Cancers in Trials.

Published in:: Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 9N
Publication type:: Article

JNM 2020 Impact Factor Rises Sharply.

Published in:: Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 9N
Publication type:: Article

Progress in Prostate Cancer Theranostics.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 11N

By:

Wahl, Richard L.

Publication type:

Article

ABNM Celebrating 50 Years.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 10N

By:

Segall, George M.

Publication type:

Article

Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1192, doi. 10.2967/jnumed.120.259697

By:

Carrasquillo, Jorge A.;
Chen, Clara C.;
Jha, Abhishek;
Pacak, Karel;
Pryma, Daniel A.;
Lin, Frank I.

Publication type:

Article

Representation of online tool of CAPTAINs platform:.

Published in:: Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1
Publication type:: Article

Towards a Universal Readout for Fluorine-18 Labelled Amyloid Tracers: The CAPTAINs Study.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.250290

By:

Bischof, Gérard N.;
Bartenstein, Peter;
Barthel, Henryk;
van Berckel, Bart;
Doré, Vincent;
van Eimeren, Thilo;
Forster, Norman;
Hammes, Jochen;
Lammertsma, Adriaan A.;
Minoshima, Satoshi;
Rowe, Chris;
Sabri, Osama;
Seibyl, John;
Van Laere, Koen;
Vandenberghe, Rik;
Villemagne, Victor;
Yakushev, Igor;
Drzezga, Alexander

Publication type:

Article

Simultaneous mapping of vasculature, hypoxia and proliferation using DSC‐MRI, 18F‐FMISO PET, and 18F‐FLT PET in relation to contrast enhancement in newly diagnosed glioblastoma.

Published in:: Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.249524
Publication type:: Article

Utility of 211At-trastuzumab for the Treatment of Metastatic Gastric Cancer in the Liver: Evaluation of a Preclinical α-Radioimmunotherapy Approach in a Clinically relevant Mouse Model.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.249300

By:

Huizi Keiko Li;
Yukie Morokoshi;
Satoshi Kodaira;
Tamon Kusumoto;
Katsuyuki Minegishi;
Hiroaki Kanda;
Kotaro Nagatsu;
Sumitaka Hasegawa

Publication type:

Article

Compound Synthesis and Characterization.

Published in:: Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1
Publication type:: Article

Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.245357

By:

Woff, Erwin;
Salvatore, Lisa;
Marmorino, Federica;
Genovesi, Dario;
Critchi, Gabriela;
Guiot, Thomas;
Ameye, Lieveke;
Sclafani, Francesco;
Hendlisz, Alain;
Flamen, Patrick

Publication type:

Article

Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.248443

By:

Eder, Ann-Christin;
Schäfer, Martin;
Schmidt, Jana;
Bauder-Wüst, Ulrike;
Roscher, Mareike;
Leotta, Karin;
Haberkorn, Uwe;
Kopka, Klaus;
Eder, Matthias

Publication type:

Article

Metabolic Scar Assessment with 18F-FDG -PET: Correlation to Ischemic VT Substrate and Successful Ablation Sites.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.246413

By:

Ghzally, Yousra;
Imanli, Hasan;
Smith, Mark;
Mahat, Jagat;
Wengen Chen;
Jimenez, Alejandro;
Sawan, Mariem A.;
Abdelmegid, Mohamed Aboel-Kassem F.;
el Rahman Helmy, Hatem Abd;
Demitry, Salwa;
See, Vincent;
Shorofsky, Stephen;
Dilsizian, Vasken;
Dickfeld, Timm

Publication type:

Article

Fundamental Statistical Concepts in Clinical Trials and Diagnostic Testing.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.245654

By:

Pugh, Stephanie L.;
Torres-Saavedra, Pedro A.

Publication type:

Article

A Microdosing Study with 99mTc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.245530

By:

Kulterer, Oana C.;
Pfaff, Sarah;
Wadsak, Wolfgang;
Garstka, Nathalie;
Remzi, Mesut;
Vraka, Chrysoula;
Nics, Lukas;
Mitterhauser, Markus;
Bootz, Franziska;
Cazzamalli, Samuele;
Krall, Nikolaus;
Neri, Dario;
Haug, Alexander R.

Publication type:

Article

Imaging Immunometabolism in Atherosclerosis.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.245407

By:

Mannes, Philip Z.;
Tavakoli, Sina

Publication type:

Article

Technological (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.246819

By:

Berger, D. M. S.;
van den Berg, N. S.;
van der Noort, V.;
van der Hiel, B.;
Valdés Olmos, R. A.;
Buckle, T. A.;
KleinJan, G. H.;
Brouwer, O. R.;
Vermeeren, L.;
Karakullukçu, B.;
van den Brekel, M. W. M.;
van de Wiel, B. A.;
Nieweg, O. E.;
Balm, A. J. M.;
van Leeuwen, F. W. B.;
Klop, W. M. C.

Publication type:

Article

Imaging calreticulin for early detection of immunogenic cell death during anticancer treatment.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.245290

By:

Dong-Yeon Kim;
Ayoung Pyo;
Misun Yun;
Ramar Thangam;
Sung-Hwan You;
Ying Zhang;
Ye-rim Jung;
Dinh-Huy Nguyen;
Akhil Venu;
Hyeon Sik Kim;
Mee Sun Yoon;
Yeongjin Hong;
Jung-Joon Min

Publication type:

Article

Radionuclide Therapy in Prostate Cancer: from standalone to combination PSMA theranostics.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.243295

By:

Sandhu, Shahneen;
Guo, Christina;
Hofman, Michael S.

Publication type:

Article

Molecular Imaging: PARP-1 and Beyond.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 34, doi. 10.2967/jnumed.120.243287

By:

Puentes, Laura N.;
Makvandi, Mehran;
Mach, Robert H.

Publication type:

Article

Relative strengths of three linearizations of receptor availability: Saturation, Inhibition, and Occupancy plots.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.117.204453

By:

Khodaii, Javad;
Araj-Khodaei, Mostafa;
Vafaee, Manouchehr S.;
Wong, Dean F.;
Gjedde, Albert

Publication type:

Article

Works matching IS 01615505 AND DT 2021 AND VI 62 AND IP 9

The Annual Journal Impact Factor Saga.

Leadership Focus on Advancing Cancer Research and Treatment: A Conversation Between Johannes Czernin, Caius Radu, and Antoni Ribas.

FDA Encourages Inclusion of Incurable Cancers in Trials.

JNM 2020 Impact Factor Rises Sharply.

Progress in Prostate Cancer Theranostics.

ABNM Celebrating 50 Years.

Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma.

Representation of online tool of CAPTAINs platform:.

Towards a Universal Readout for Fluorine-18 Labelled Amyloid Tracers: The CAPTAINs Study.

Simultaneous mapping of vasculature, hypoxia and proliferation using DSC‐MRI, <sup>18</sup>F‐FMISO PET, and <sup>18</sup>F‐FLT PET in relation to contrast enhancement in newly diagnosed glioblastoma.

Utility of <sup>211</sup>At-trastuzumab for the Treatment of Metastatic Gastric Cancer in the Liver: Evaluation of a Preclinical α-Radioimmunotherapy Approach in a Clinically relevant Mouse Model.

Compound Synthesis and Characterization.

Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.

Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules.

Metabolic Scar Assessment with <sup>18</sup>F-FDG -PET: Correlation to Ischemic VT Substrate and Successful Ablation Sites.

Fundamental Statistical Concepts in Clinical Trials and Diagnostic Testing.

A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.

Imaging Immunometabolism in Atherosclerosis.

Technological (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region.

Imaging calreticulin for early detection of immunogenic cell death during anticancer treatment.

Radionuclide Therapy in Prostate Cancer: from standalone to combination PSMA theranostics.

Molecular Imaging: PARP-1 and Beyond.

Relative strengths of three linearizations of receptor availability: Saturation, Inhibition, and Occupancy plots.